A Study of the Drug LBP-EC01 for the Treatment of Urinary Tract Infections

About This Study

The goal of this study is to learn more about the drug LBP-EC01. We want to see if it is safe and helpful for treating females with frequent or recurrent urinary tract infection (UTI) caused by a bacteria called E. coli but particularly E. coli that is resistant to at least one antibiotic.

Volunteers need to have had a UTI in the past year and a prior or current UTI caused by AMR E. coli. Study team will provide more information.

What Activities Are a Part of this Study?

Informed Consent Review
Use of Study Treatments or Placebo
After Study Follow-Up Activities
Review of Medical History
Physical Examinations
Phone Calls and/or Emails
Study Visits and Consultations
Laboratory and Imaging Tests
Specimen Sample Collection
Diary/e-Diary Writing or Recordings

Age & Gender

18 - 75 years old
Female at Birth

Language

This study enrolls English and Spanish speakers

Additional Study Information

Compensation Offered
No reimbursement offered

Study Locations

Greater Winston-Salem, NC

Study Topics

Kidneys, Liver, Pancreas

Study Locations and Contacts

Greater Winston-Salem, NC: Rica Abbott rabbott@wakehealth.edu

Study Information
IRB Number: IRB00109631

Helpful Information

Have questions? See if your question is answered in our most common question and answers section. Need to know what something means? Browse the dictionary for explanation of common clinical study terms.